"Embarking on exports to Israel and Australia signifies a pivotal chapter for Klonetics Plant Science. It underscores our dedication to the global cannabis industry and our vision for international access to premium cannabis," says David Brough, CEO of Klonetics. The company announced that they're extending their global footprint by exporting to Israel and Australia. "We're poised for collaboration, eager for research opportunities, and ready to contribute to the advancement of cannabis science. This milestone celebrates our team's hard work and expertise, and we're optimistic about the positive impact we'll have in these new markets."
According to the company, the journey into these new markets is underpinned by several aspects. First of all, quality assurance: "Our exported products maintain the same commitment to quality and consistency that has become synonymous with the Klonetics brand." Also, the quality of cultivation is important. "We continue to leverage cutting-edge cultivation practices, ensuring the delivery of top-tier cannabis products that meet and exceed international standards." Strategic partnerships are also key: "We have established meaningful partnerships with leading entities in Israel and Australia, fostering collaborative efforts to advance cannabis research, development, and accessibility." Lastly, regulatory compliance: "Adhering to all relevant regulations in both Israel and Australia, Klonetics Plant Science demonstrates its commitment to ethical and responsible cannabis business practices."
"Successfully launching cannabis exports to Israel and Australia is a testament to our dedication and the strong partnerships we've cultivated. These new markets represent a significant opportunity for growth and further contribution to the global cannabis community," David adds.
For more information:
Klonetics Plant Science
www.klonetics.com